Aminobenzoic acids and derivatives
Aobchem N-isopropyl-3-nitrobenzamide | ≥95% | CAS 50445-53-9 | C10H12N2O3 | 500mg
N-isopropyl-3-nitrobenzamide | ≥95% | CAS 50445-53-9 | C10H12N2O3 | 500mg
Medchemexpress LLC Zacopride hydrochloride | 101303-98-4 | MFCD04971977 | 99.7% | 346.25 g/mol | C15H21Cl2N3O2 | 25 MG
Zacopride hydrochloride is a research-grade small molecule acting as a potent 5-HT3 receptor antagonist and a 5-HT4 receptor agonist, supplied for preclinical and in vitro studies. It is provided at research-grade purity and in small pack sizes suitable for laboratory use.
- Orally active 5-HT3 receptor antagonist and 5-HT4 receptor agonist.
- High purity (99.69%).
- Available in small research pack sizes, including 25 MG.
- Molecular weight 346.25 g/mol; formula C15H21Cl2N3O2.
- Intended for research use only; not for human or veterinary use.
Medchemexpress LLC 4-Aminobenzamide | 2835-68-9 | MFCD00007999 | 98.7% | 136.15 g/mol | C7H8N2O | 100 G
4-Aminobenzamide (C7H8N2O, CAS 2835-68-9) is a small-molecule biochemical reagent used in life-science research. It serves as an aromatic amide building block in organic synthesis and as a reagent in biochemical assays. The product is supplied as a high-purity solid with recommended storage at 4°C and protection from light; solvent storage conditions are provided for long-term stability.
- High purity suitable for research applications.
- White to off-white solid appearance.
- Molecular weight 136.15 g/mol.
- Recommended storage at 4°C, protect from light.
- In solvent: stable at -80°C for months or -20°C for short term.
- Available in multiple pack sizes including 100 g.
Enzo Life Sciences M344 (5mg). CAS: 251456-60-7
Potent inhibitor of histone deacetylases (HDACs) (IC50≤1µM). Alternative name: 4-Dimethylamino-N-(6-hydroxycarbamoylhexyl)-benzamide. Formula: C16H25N3O3. MW: 307.4. Purity: ≥98% (HPLC). Appearance: White crystalline solid. Solubility: Soluble in DMSO (1mg/ml). Long Term Storage: +4°C. Handling: Protect from light.
eMolecules 101421-85-6 | 2-Bromo-3-methylbenzamide | Oakwood Chemical | MFCD09753713 | 214.062 | C8H8BrNO | 0.000 | Cc1cccc(C(N)=O)c1Br | 1g | 537722706
2-Bromo-3-methylbenzamide | Oakwood Chemical | 101421-85-6 | MFCD09753713 | 214.062 | C8H8BrNO | 0.000 | Cc1cccc(C(N)=O)c1Br | 1g | 537722706
eMolecules 25900-61-2 | 3-Amino-N-methylbenzamide | Synthonix | MFCD00070630 | 150.181 | C8H10N2O | 95.000 | CNC(=O)c1cccc(N)c1 | 5g | 571832998
3-Amino-N-methylbenzamide | Synthonix | 25900-61-2 | MFCD00070630 | 150.181 | C8H10N2O | 95.000 | CNC(=O)c1cccc(N)c1 | 5g | 571832998
Apexbio Technology LLC Zacopride hydrochloride 101303-98-4 10mg
Zacopride hydrochloride (CAS 101303-98-4) is a small molecule that functions as a high-affinity antagonist at 5-HT sub 3 /sub receptors ( i K sub i /sub /i 0 38 nM) and as an agonist at 5-HT sub 4 /sub receptors ( i K sub i /sub /i 373 nM) These receptors are subtypes of serotonin (5-HT) receptors involved in modulating neurotransmission in central and peripheral systems In human adrenocortical tissue zacopride hydrochloride induces aldosterone secretion in a dose-dependent manner with an effective concentration as low as 10 sup -10 /sup mol/L and half-maximal stimulation at 7 10 sup -8 /sup mol/L In vivo oral administration of 400 g zacopride increased plasma aldosterone without affecting renin adrenocorticotropic hormone or cortisol Zacopride hydrochloride is valuable for studying serotonergic regulation of adrenal steroidogenesis and receptor pharmacology
Aobchem 2-Bromo-5-nitrobenzamide | ≥97% | CAS 41052-26-0 | C7H5BrN2O3 | 1g
2-Bromo-5-nitrobenzamide | ≥97% | CAS 41052-26-0 | C7H5BrN2O3 | 1g
Aobchem 3-Iodo-2-methylbenzamide | 95% | CAS 52107-88-7 | C8H8INO | 500mg
3-Iodo-2-methylbenzamide | 95% | CAS 52107-88-7 | C8H8INO | 500mg
Aobchem 3-Iodo-2-methylbenzamide | 95% | CAS 52107-88-7 | C8H8INO | 250mg
3-Iodo-2-methylbenzamide | 95% | CAS 52107-88-7 | C8H8INO | 250mg
eMolecules 2835-68-9 | 4-aminobenzamide | Combi-Blocks | MFCD00007999 | 136.154 | C7H8N2O | 98.000 | NC(=O)c1ccc(N)cc1 | 5g | 290684905
4-aminobenzamide | Combi-Blocks | 2835-68-9 | MFCD00007999 | 136.154 | C7H8N2O | 98.000 | NC(=O)c1ccc(N)cc1 | 5g | 290684905
Medchemexpress LLC Encequidar mesylate | 849675-87-2 | 99.8% | 784.83 | 100 MG
Encequidar mesylate is a competitive and potent P-glycoprotein inhibitor intended for research use only. It has demonstrated significant inhibition of survival in in vitro studies and improved absorption in vivo when administered in microcapsule form due to enhanced aqueous solubility and dissolution.
- Competitive and potent p-glycoprotein inhibitor
- Enhances absorption through improved aqueous solubility
- Provides faster Tmax and higher AUC values in microcapsule form
- Demonstrates inhibition of survival in in vitro studies
Medchemexpress LLC Pamufetinib mesylate | 1688673-09-7 | 99.2% | 614.66 | C28H27FN4O7S2 | 25MG
Pamufetinib mesylate is a research-stage small-molecule kinase inhibitor that targets vascular endothelial growth factor receptors (VEGFR) and hepatocyte growth factor receptor (c-Met/HGFR). It exhibits low-nanomolar inhibition of recombinant VEGFR2 and MET and is used in preclinical studies of angiogenesis and MET-driven signaling in oncology research. The compound is provided as the mesylate salt for laboratory use and should be stored under controlled conditions to maintain stability.
- Provides low-nanomolar inhibition of VEGFR2 and MET (IC50 ≈ 30-32 nM).
- Suitable for preclinical studies of angiogenesis and MET-dependent signaling.
- High chemical purity as confirmed by batch analysis (~99.2%).
- Mesylate salt form for convenient laboratory handling.
- Stable when stored under recommended conditions to preserve activity.
Apexbio Technology LLC Bromocriptine mesylate 22260-51-1 10mM (in 1mL DMSO)
Bromocriptine mesylate (CAS 22260-51-1) is a selective agonist of D -like dopamine receptors exhibiting high affinity with a pKi of 8 05 0 2 Through modulation of D receptor activity bromocriptine mesylate influences metabolic processes by reducing glucose intolerance and insulin resistance inhibits pituitary prolactin secretion and enhances motor function relevant to Parkinson s disease The compound has established applications in research on metabolic disorders neuroendocrine regulation and neurodegenerative diseases including studies pertaining to type 2 diabetes prolactinomas acromegaly and Parkinson s disease
Medchemexpress LLC Pritelivir (mesylate) | 1428333-96-3 | C19H22N4O6S3 | 25 MG
Pritelivir mesylate is a potent inhibitor of the viral helicase-primase complex, demonstrating significant antiviral activity against herpes simplex virus types 1 and 2 (HSV-1 and HSV-2). It represents a novel class of antiviral agents with potential for treating severe HSV infections.
- Inhibits viral helicase-primase complex
- Shows antiviral activity against HSV-1 and HSV-2 with an IC50 of 0.02 μM
- Increases survival in animal models of HSV infection
- Exhibits resistance-breaking antiviral efficacy
- Potential treatment for life-threatening HSV type 1 and 2 infections